GREENLIGHT CAPITAL RE LTD-A (GLRE)

KYG4095J1094 - Common Stock

13.9  0 (0%)

After market: 13.9 0 (0%)

Fundamental Rating

4

GLRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. GLRE has only an average score on both its financial health and profitability. GLRE has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

GLRE had positive earnings in the past year.
GLRE had a positive operating cash flow in the past year.
Of the past 5 years GLRE 4 years were profitable.
In multiple years GLRE reported negative operating cash flow during the last 5 years.

1.2 Ratios

GLRE has a Return On Assets of 4.39%. This is in the better half of the industry: GLRE outperforms 75.71% of its industry peers.
GLRE has a Return On Equity of 13.24%. This is comparable to the rest of the industry: GLRE outperforms 56.43% of its industry peers.
Industry RankSector Rank
ROA 4.39%
ROE 13.24%
ROIC N/A
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GLRE's Profit Margin of 13.31% is fine compared to the rest of the industry. GLRE outperforms 72.14% of its industry peers.
GLRE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.03%, GLRE is in line with its industry, outperforming 49.29% of the companies in the same industry.
In the last couple of years the Operating Margin of GLRE has grown nicely.
Industry RankSector Rank
OM 9.03%
PM (TTM) 13.31%
GM N/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GLRE has been increased compared to 1 year ago.
GLRE has less shares outstanding than it did 5 years ago.
GLRE has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of GLRE is 0.60, which is an excellent value as it means it would take GLRE, only 0.60 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GLRE (0.60) is better than 75.00% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that GLRE is not too dependend on debt financing.
GLRE's Debt to Equity ratio of 0.09 is amongst the best of the industry. GLRE outperforms 81.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.6
Altman-Z N/A
ROIC/WACCN/A
WACC8.67%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The earnings per share for GLRE have decreased by -9.68% in the last year.
GLRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 151.28% yearly.
Looking at the last year, GLRE shows a small growth in Revenue. The Revenue has grown by 6.33% in the last year.
Measured over the past years, GLRE shows a very strong growth in Revenue. The Revenue has been growing by 30.32% on average per year.
EPS 1Y (TTM)-9.68%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%158.97%
Revenue 1Y (TTM)6.33%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%5.1%

3.2 Future

The Earnings Per Share is expected to decrease by -11.82% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.57%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.52, which indicates a rather cheap valuation of GLRE.
Based on the Price/Earnings ratio, GLRE is valued a bit cheaper than 78.57% of the companies in the same industry.
GLRE is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.52, the valuation of GLRE can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GLRE indicates a somewhat cheap valuation: GLRE is cheaper than 69.29% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, GLRE is valued rather cheaply.
Industry RankSector Rank
PE 5.52
Fwd PE 8.52

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GLRE indicates a somewhat cheap valuation: GLRE is cheaper than 67.14% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GLRE is valued a bit cheaper than 72.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.65
EV/EBITDA 8.25

4.3 Compensation for Growth

GLRE's earnings are expected to decrease with -11.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (12/20/2024, 8:14:58 PM)

After market: 13.9 0 (0%)

13.9

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners45.2%
Inst Owner Change2.18%
Ins Owners25.78%
Ins Owner Change0.55%
Market Cap484.14M
Analysts43.33
Price TargetN/A
Short Float %0.62%
Short Ratio1.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.27%
Min EPS beat(2)-9.8%
Max EPS beat(2)52.34%
EPS beat(4)2
Avg EPS beat(4)13.71%
Min EPS beat(4)-9.8%
Max EPS beat(4)52.34%
EPS beat(8)6
Avg EPS beat(8)75.52%
EPS beat(12)6
Avg EPS beat(12)-66.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)18.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.52
Fwd PE 8.52
P/S 0.73
P/FCF 4.65
P/OCF 4.65
P/B 0.73
P/tB 0.73
EV/EBITDA 8.25
EPS(TTM)2.52
EY18.13%
EPS(NY)1.63
Fwd EY11.74%
FCF(TTM)2.99
FCFY21.5%
OCF(TTM)2.99
OCFY21.5%
SpS18.94
BVpS19.05
TBVpS19.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 13.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.03%
PM (TTM) 13.31%
GM N/A
FCFM 15.78%
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.6
Debt/EBITDA 1.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.63
Cash Conversion 174.64%
Profit Quality 118.52%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%158.97%
EPS Next Y-3.57%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)6.33%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%5.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.55%
EBIT growth 3Y98.58%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y260.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y260.31%
OCF growth 3YN/A
OCF growth 5YN/A